Hepatitis B Virus X Protein-induced Aberrant Epigenetic Modifications Contributing to Human Hepatocellular Carcinoma Pathogenesis

Overview

Journal Mol Cell Biol

Specialty Cell Biology

Date 2013 May 30

PMID 23716588

Citations 78

Authors

Yi Tian

Weibing Yang

Jianxun Song

Yuzhang Wu

Bing Ni

Affiliations

Soon will be listed here.

Abstract

Hepatocellular carcinoma (HCC) remains one of the most prevalent malignant diseases worldwide, and the majority of cases are related to hepatitis B virus (HBV) infection. Interactions between the HBV-encoded X (HBx) protein and host factors are known to play major roles in the onset and progression of HBV-related HCC. These dynamic molecular mechanisms are extremely complex and lead to prominent changes in the host genetic and epigenetic architecture. This review summarizes the current knowledge about HBx-induced epigenetic changes, including aberrations in DNA methylation, histone modifications, and microRNA expression, and their roles in HBV-infected liver cells and HBV-related HCC. Moreover, the HBx-mediated epigenetic control of HBV covalently closed circular DNA (cccDNA) is also discussed. Although this field of study is relatively new, the accumulated evidence has indicated that the epigenetic events induced by HBx play important roles in the development of HBV-related HCC. Ongoing research will help to identify practical applications of the HBV-related epigenetic signatures as biomarkers for early HCC detection or as potential targets to prevent and treat HBV-related HCC.

Citing Articles

Current status and new directions for hepatocellular carcinoma diagnosis.

Tu J, Wang B, Wang X, Huo K, Hu W, Zhang R Liver Res. 2025; 8(4):218-236.

PMID: 39958920 PMC: 11771281. DOI: 10.1016/j.livres.2024.12.001.

Association of Chronic Hepatitis B With Colorectal Cancer and Its Dual Impact on Colorectal Liver Metastasis: A Narrative Review.

Kaur A, Azeez G, Thirunagari M, Fatima N, Anand A, Palvia A Cureus. 2025; 16(12):e76079.

PMID: 39835087 PMC: 11743875. DOI: 10.7759/cureus.76079.

Role of the mA demethylase ALKBH5 in gastrointestinal tract cancer (Review).

Zhang L, Jing M, Song Q, Ouyang Y, Pang Y, Ye X Int J Mol Med. 2024; 55(2).

PMID: 39611478 PMC: 11637504. DOI: 10.3892/ijmm.2024.5463.

USP26 as a hepatitis B virus-induced deubiquitinase primes hepatocellular carcinogenesis by epigenetic remodeling.

Ma M, Yi L, Pei Y, Zhang Q, Tong C, Zhao M Nat Commun. 2024; 15(1):7856.

PMID: 39251623 PMC: 11385750. DOI: 10.1038/s41467-024-52201-z.

Exosomal miR-223-3p from bone marrow mesenchymal stem cells targets HDAC2 to downregulate STAT3 phosphorylation to alleviate HBx-induced ferroptosis in podocytes.

Chen Y, Yang X, Feng M, Yu Y, Hu Y, Jiang W Front Pharmacol. 2024; 15:1327149.

PMID: 38444939 PMC: 10912342. DOI: 10.3389/fphar.2024.1327149.

References

Lee Y, Hwang J, Im J, Lee Y, Kim N, Kim D . Human hepatitis B virus-X protein alters mitochondrial function and physiology in human liver cells. J Biol Chem. 2004; 279(15):15460-71. DOI: 10.1074/jbc.M309280200. View

Chan H, La Thangue N . p300/CBP proteins: HATs for transcriptional bridges and scaffolds. J Cell Sci. 2001; 114(Pt 13):2363-73. DOI: 10.1242/jcs.114.13.2363. View

Shan C, Zhang S, Cui W, You X, Kong G, DU Y . Hepatitis B virus X protein activates CD59 involving DNA binding and let-7i in protection of hepatoma and hepatic cells from complement attack. Carcinogenesis. 2011; 32(8):1190-7. DOI: 10.1093/carcin/bgr106. View

Mahe Y, Mukaida N, Kuno K, Akiyama M, Ikeda N, Matsushima K . Hepatitis B virus X protein transactivates human interleukin-8 gene through acting on nuclear factor kB and CCAAT/enhancer-binding protein-like cis-elements. J Biol Chem. 1991; 266(21):13759-63. View

Chirillo P, Pagano S, Natoli G, Puri P, Burgio V, Balsano C . The hepatitis B virus X gene induces p53-mediated programmed cell death. Proc Natl Acad Sci U S A. 1997; 94(15):8162-7. PMC: 21574. DOI: 10.1073/pnas.94.15.8162. View

Osada T, Sakamoto M, Ino Y, Iwamatsu A, Matsuno Y, Muto T . E-cadherin is involved in the intrahepatic metastasis of hepatocellular carcinoma. Hepatology. 1996; 24(6):1460-7. DOI: 10.1053/jhep.1996.v24.pm0008938181. View

Herceg Z . Epigenetics and cancer: towards an evaluation of the impact of environmental and dietary factors. Mutagenesis. 2007; 22(2):91-103. DOI: 10.1093/mutage/gel068. View

Li B, Carey M, Workman J . The role of chromatin during transcription. Cell. 2007; 128(4):707-19. DOI: 10.1016/j.cell.2007.01.015. View

Yang L, He J, Chen L, Wang G . Hepatitis B virus X protein upregulates expression of SMYD3 and C-MYC in HepG2 cells. Med Oncol. 2008; 26(4):445-51. DOI: 10.1007/s12032-008-9144-1. View

10.

Kouzarides T . Chromatin modifications and their function. Cell. 2007; 128(4):693-705. DOI: 10.1016/j.cell.2007.02.005. View

11.

OConnor D, Bergamaschi D, Trigiante G, Hsieh J, Zhong S, Campargue I . ASPP proteins specifically stimulate the apoptotic function of p53. Mol Cell. 2001; 8(4):781-94. DOI: 10.1016/s1097-2765(01)00367-7. View

12.

Jung J, Park S, Jang K . Hepatitis B virus X protein overcomes the growth-inhibitory potential of retinoic acid by downregulating retinoic acid receptor-beta2 expression via DNA methylation. J Gen Virol. 2009; 91(Pt 2):493-500. DOI: 10.1099/vir.0.015149-0. View

13.

Pogribny I, Rusyn I . Role of epigenetic aberrations in the development and progression of human hepatocellular carcinoma. Cancer Lett. 2012; 342(2):223-30. PMC: 3971756. DOI: 10.1016/j.canlet.2012.01.038. View

14.

Wang Y, Lu Y, Toh S, Sung W, Tan P, Chow P . Lethal-7 is down-regulated by the hepatitis B virus x protein and targets signal transducer and activator of transcription 3. J Hepatol. 2010; 53(1):57-66. DOI: 10.1016/j.jhep.2009.12.043. View

15.

Zhang X, Liu S, Hu T, Liu S, He Y, Sun S . Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression. Hepatology. 2009; 50(2):490-9. DOI: 10.1002/hep.23008. View

16.

Vaissiere T, Sawan C, Herceg Z . Epigenetic interplay between histone modifications and DNA methylation in gene silencing. Mutat Res. 2008; 659(1-2):40-8. DOI: 10.1016/j.mrrev.2008.02.004. View

17.

Ng S, Lee C . Hepatitis B virus X gene and hepatocarcinogenesis. J Gastroenterol. 2011; 46(8):974-90. DOI: 10.1007/s00535-011-0415-9. View

18.

Jung J, Arora P, Pagano J, Jang K . Expression of DNA methyltransferase 1 is activated by hepatitis B virus X protein via a regulatory circuit involving the p16INK4a-cyclin D1-CDK 4/6-pRb-E2F1 pathway. Cancer Res. 2007; 67(12):5771-8. DOI: 10.1158/0008-5472.CAN-07-0529. View

19.

Chen G, Li M, Ho R, Chak E, Lau W, Lai P . Identification of hepatitis B virus X gene mutation in Hong Kong patients with hepatocellular carcinoma. J Clin Virol. 2005; 34(1):7-12. DOI: 10.1016/j.jcv.2005.01.006. View

20.

Tu H, Bonura C, Giannini C, Mouly H, Soussan P, Kew M . Biological impact of natural COOH-terminal deletions of hepatitis B virus X protein in hepatocellular carcinoma tissues. Cancer Res. 2001; 61(21):7803-10. View